Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be participating in three upcoming investor conferences. Infinity will provide an overview of its business at the following conferences:
- Credit Suisse 2013 Healthcare Conference, Phoenix, AZ, November 13, 2013, 9:00 a.m. MT (11:00 a.m. ET)
- 2013 Deutsche Bank BioFEST, Boston, MA, December 2, 2013, 10:10 a.m. ET
Additionally, on November 21, 2013, Infinity will participate in meetings at RBC Capital Markets’ Denver Healthcare Investor Day in Denver, CO.
Live audio webcasts of Infinity’s presentations at the Credit Suisse and Deutsche Bank conferences will be accessible from the “Investors/Media” section of the company’s website, www.infi.com, and replays will be available for 30 days following each event.
About Infinity Pharmaceuticals, Inc.Infinity is an innovative biopharmaceutical company dedicated to discovering, developing and delivering best-in-class medicines to people with difficult-to-treat diseases. Infinity combines proven scientific expertise with a passion for developing novel small molecule drugs that target emerging disease pathways. For more information on Infinity, please refer to the company’s website at
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts